NervGen Pharma Corp. Common stock
Status: Publicly traded
Last reviewed: October 2026
Direct answer
NervGen Pharma Corp. Common stock is publicly traded on NASDAQ under the ticker NGEN.
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and...
Can you invest in NervGen Pharma Corp. Common stock?
Yes. NervGen Pharma Corp. Common stock is publicly traded on NASDAQ under the ticker NGEN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for NervGen Pharma Corp. Common stock
Detailed equity research is provided by MarketSnap.